Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 123

1.

A Japanese approach for CKD-MBD.

Yokoyama K, Taniguchi M, Fukagawa M.

Kidney Int Suppl (2011). 2013 Dec;3(5):451-456. Review.

2.

Treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD).

Komaba H, Tanaka M, Fukagawa M.

Intern Med. 2008;47(11):989-94. Epub 2008 Jun 2. Review.

3.

[CKD-MBD (Chronic Kidney Disease-Mineral and Bone Disorder). Paradigm shift in CKD-MBD guideline].

Yokoyama K.

Clin Calcium. 2010 Jul;20(7):1012-20. doi: CliCa100710121020. Review. Japanese.

PMID:
20585179
4.
5.

[Kidney and bone update : the 5-year history and future of CKD-MBD. About the guideline of the Japanese Society for Dialysis Therapy].

Yokoyama K.

Clin Calcium. 2012 Jul;22(7):979-86. doi: CliCa1207979986. Review. Japanese.

PMID:
22750929
6.

[CKD-MBD (Chronic Kidney Disease-Mineral and Bone Disorder). Parathyroid interventions: final one piece in the management of uremic SHPT patients].

Uemura K, Kakuta T.

Clin Calcium. 2010 Jul;20(7):1104-10. doi: CliCa100711041110. Review. Japanese.

PMID:
20585190
7.

Effects of unfractionated heparin on renal osteodystrophy and vascular calcification in chronic kidney disease rats.

Meng Y, Zhang H, Li Y, Li Q, Zuo L.

Bone. 2014 Jan;58:168-76. doi: 10.1016/j.bone.2013.10.010. Epub 2013 Oct 18.

PMID:
24145307
8.

[CKD-MBD (Chronic Kidney Disease-Mineral and Bone Disorder). Role of cinacalcet in the treatment of CKD-MBD].

Koiwa F, Maruta Y.

Clin Calcium. 2010 Jul;20(7):1089-95. doi: CliCa100710891095. Review. Japanese.

PMID:
20585188
9.

[Parathyroid and bone. Management of parathyroid function and evaluation of bone metabolism in hemodialysis patients].

Goto S, Fukagawa M.

Clin Calcium. 2007 Dec;17(12):1830-4. Review. Japanese.

PMID:
18057657
10.

Is chronic kidney disease-mineral bone disorder (CKD-MBD) really a syndrome?

Cozzolino M, Ureña-Torres P, Vervloet MG, Brandenburg V, Bover J, Goldsmith D, Larsson TE, Massy ZA, Mazzaferro S; CKD-MBD Working Group of ERA-EDTA.

Nephrol Dial Transplant. 2014 Oct;29(10):1815-20. doi: 10.1093/ndt/gft514. Epub 2014 Feb 9.

PMID:
24516228
11.

[Chronic kidney disease-mineral and bone disorder (CKD-MBD)].

Hamada Y, Fukagawa M.

Nihon Rinsho. 2006 Sep;64(9):1703-6. Review. Japanese.

PMID:
16972683
12.

KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD).

Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group.

Kidney Int Suppl. 2009 Aug;(113):S1-130. doi: 10.1038/ki.2009.188.

PMID:
19644521
13.

[Guideline for the management of chronic kidney disease-related mineral and bone disorders (CKD-MBD)].

Kakuta T.

Clin Calcium. 2007 May;17(5):752-9. Review. Japanese.

PMID:
17471006
14.

[CKD-MBD (chronic kidney disease-mineral and bone disorder). CKD-MBD: chronic kidney disease-mineral and bone disorder].

Mizobuchi M, Aoshima Y, Akizawa T.

Clin Calcium. 2010 Jul;20(7):995-1003. doi: CliCa10079951003. Review. Japanese.

PMID:
20585177
15.

KDOQI US commentary on the 2009 KDIGO Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of CKD-Mineral and Bone Disorder (CKD-MBD).

Uhlig K, Berns JS, Kestenbaum B, Kumar R, Leonard MB, Martin KJ, Sprague SM, Goldfarb S.

Am J Kidney Dis. 2010 May;55(5):773-99. doi: 10.1053/j.ajkd.2010.02.340. Epub 2010 Apr 3.

PMID:
20363541
16.

Impact of cinacalcet introduction on MBD management: the MBD-5D study in Japan.

Fukuma S, Kurita N, Fukagawa M, Akizawa T, Fukuhara S.

Kidney Int Suppl (2011). 2013 Dec;3(5):436-441. Review.

17.

The new kidney disease: improving global outcomes (KDIGO) guidelines - expert clinical focus on bone and vascular calcification.

London G, Coyne D, Hruska K, Malluche HH, Martin KJ.

Clin Nephrol. 2010 Dec;74(6):423-32. Erratum in: Clin Nephrol. 2013 Jul;80(1):80.

18.

[Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)].

Lorenzo Sellares V, Torregrosa V.

Nefrologia. 2008;28 Suppl 3:67-78. Spanish.

19.

Revisiting KDIGO clinical practice guideline on chronic kidney disease-mineral and bone disorder: a commentary from a Kidney Disease: Improving Global Outcomes controversies conference.

Ketteler M, Elder GJ, Evenepoel P, Ix JH, Jamal SA, Lafage-Proust MH, Shroff R, Thadhani RI, Tonelli MA, Kasiske BL, Wheeler DC, Leonard MB.

Kidney Int. 2015 Mar;87(3):502-28. doi: 10.1038/ki.2014.425. Epub 2015 Feb 4.

PMID:
25651364
20.

Prevention and control of phosphate retention/hyperphosphatemia in CKD-MBD: what is normal, when to start, and how to treat?

Martin KJ, González EA.

Clin J Am Soc Nephrol. 2011 Feb;6(2):440-6. doi: 10.2215/CJN.05130610. Epub 2011 Feb 3. Review.

Items per page

Supplemental Content

Write to the Help Desk